Prevalence of Use Study for Amphetamine (AMP), Methamphetamine (MAMP), 3,4-Methylenedioxyamphetamine (MDA) 3,4-Methylenedioxymethamphetamine (MDMA), and 3,4-Methylenedioxyethylamphetamine (MDEA) in Military Entrance Processing Stations (MEPS) Specimens
Journal of Analytical Toxicology June 1, 2006 K. L. Klette, A. R. Kettle, M. H. Jamerson 13 citations
Over four months, 85,658 urine specimens from applicants to the United States Armed Forces were screened for amphetamine, methamphetamine, MDA, MDMA, and MDEA using two immunoassays. The Roche Online Amphetamine immunoassay flagged 216 specimens as presumptively positive; 70 confirmed positive for amphetamine and 87 for amphetamine and/or methamphetamine, a 73% confirmation rate. The Microgenics DRI Ecstasy immunoassay flagged eight specimens; five confirmed positive for MDMA and/or MDA, a 63% confirmation rate. The overall prevalence of any of these drugs in military entrance processing stations specimens was 0.19%.